Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Research and Markets
DUBLIN, Dec. 16, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/k8hhr8/peptide) has announced the addition of the "Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" report to their offering.
Peptide therapeutics is currently offering a new commercial potential to pharmaceuticals and biotechnology industry. To exploit this emerging market, large pharmaceutical and biotechnological firms are actively investing in development of newer peptides for various applications and are also opting for newer technologies for syntheses of these peptides. Cancer is the leading cause of death globally; according to the WHO (World Health Organization), around 12.7 million new cancer cases occurred in the year 2008. About 7 million people die from cancer every year and it is estimated that there will be more than 16 million new cancer cases every year by 2020. With rise in cancer patients and metabolic diseases like diabetes, there has been a push in growth for peptide molecules since chemotherapy, which is the major mode of treatment for cancer, is facing major challenges due to its inability to deliver the correct amount of drug directly. In addition, it affects the normal cells in the body.
Likewise, peptide application in various other treatments has opened a promising avenue for future growth of this market. New routes of peptide administration are being investigated; however the parenteral route continues to dominate this market and accounted for a share of almost 86% of the entire market. Similarly, the technology market is ruled by LPPS (long phase peptide syntheses) and is anticipated to decline owing to huge demand for solid phase peptide syntheses and hybrid syntheses.
This report analyzes the peptide therapeutics market by types of applications (cancer, metabolic, neurological diseases and others), route of administration, by types (innovative and generic), by API therapeutics market (in-house vs. CMO), by peptide therapeutics, and technology. Each of these markets is analyzed by studying the current and future market scenario, with estimation for the period 2010 - 2018 in terms of value in USD million.
Key Topics Covered:
1.1 Report description
1.2 Market segmentation
1.3 Scope of the report
1.4 Research methodology
2 Executive Summary
3 Global Peptide Therapeutics Market Dynamics
3.3 Restraints & challenges
3.5 Porters five forces analysis
3.6 Market attractiveness analysis
3.7 Peptide therapeutics - emerging technologies & trends
3.8 Regulatory policies
4 Global Peptide Therapeutics Market Analysis, By Applications
5 Global Peptide Therapeutics Market, by Route of Administration
5.2 Parenteral Route
5.3 Oral Route
5.4 Pulmonary Route
5.5 Mucosal Route
5.6 Others (Intradermal & Nasal)
6 Peptide Therapeutics Market - Generic & Innovative Segments
6.2 Peptide Therapeutics - Innovative market
6.3 Peptide Therapeutics - Generic market
7 API Peptide Therapeutics Market, In-house Vs CMO
7.2 API peptide therapeutics - In-house market
7.3 Contract Manufacturing Organizations (CMO)
8 Peptide Therapeutics Market, By Technology
8.2 Solid Phase Peptide Synthesis (SPPS)
8.3 Liquid Phase Peptide Synthesis (LPPS)
8.4 Hybrid Technology
9 Peptide Therapeutics Market, By Geography
9.2 North America
9.5 Rest of World
10 Market Share Analysis
10.1 Market share by key players
10.2 Market share by key players in peptide drugs market
10.3 Market share by key players in CMO segment
11.1 Success strategies
11.2 Barriers to be considered
12 Company Profiles
For more information visit http://www.researchandmarkets.com/research/k8hhr8/peptide
Laura Wood , +353-1-481-1716, firstname.lastname@example.org
©2012 PR Newswire. All Rights Reserved.